Your cart is empty.
UK Biocentre has been central to the UK Government’s response to the COVID-19 pandemic, repurposing its entire facility to become a national center for SARS-CoV-2 molecular testing. To help meet an ambitious target of 100,000 tests per day across the country, the organization has established a new mega-lab, partnering with Tecan to design and commission a suite of liquid handling automation platforms in just a few weeks.
Understanding how and when laboratory automation assets are being used is crucial to maximize productivity and enable effective resource planning in high throughput facilities. California’s Ambry Genetics has a portfolio of almost 60 Fluent® and Freedom EVO® liquid handling platforms, and has worked closely with Tecan on the development of Introspect™, a cloud-based service that provides a comprehensive overview of precisely when and how laboratory automation systems are being used.